We Help Individuals Suffering Severe Side Effects from Actos
Approved by the FDA in 1999, Actos (pioglitazone), is a medication that was intended to help patients who have type II diabetes or who have symptoms of the disease. Takeda and Eli Lilly, Big Pharma companies, are the manufacturers and distributors, which makes billions in sales every year. Interestingly enough, this drug is banned in Europe because it has linked to bladder cancer.
In 2011, the FDA partially followed suit and issued a warning about this risk. Taking Actos for just one year has the potential to increase the risk of bladder cancer by 40 percent. To effectively pursue compensation for the harmful side effects of this drug, it’s crucial that you retain the legal services of our law firm. At Handler Henning & Rosenberg, LLP, our firm has an established reputation built on our commitment to ethics, integrity, and hard work. Since 1922, we have recovered millions in verdicts and settlements for our clients. As one of the largest firms in the area, we have extensive resources and experience to devote to your case.
Call (888) 498-3023 to learn more about your legal options in a free case evaluation!
Why Are Actos Manufacturers Responsible?
Those who have developed bladder cancer as a result of taking Actos have every right to fight for just compensation that will cover their medical bills, lost wages, and more. Actos manufacturers are being held responsible for the following:
- Failure to warn the public about the risks of bladder cancer
- Manufacturing a defective product
- Failing to properly test Actos
- Concealing data from the public
- Providing misleading data to the public
Hold the Manufacturers Responsible with a Pennsylvania Defective Drugs Lawyer!
What many are enraged by is that the makers of Actos knew the dangers of the product, but sold it anyway in order to maximize profits. It’s time to put an end to the dishonest dealings associated with Actos. Get help from our firm today.
Contact Handler, Henning & Rosenberg LLP today to begin a free consultation: (888) 498-3023.